on-Interventional Study to Assess the Clinical Outcome in Patients Treated for Poorly Differentiated (High-Grade, G3) Neuroendocrine Carcinomas Except Primary Lung Cancer
Recruiting
- Conditions
- Poorly differentiated (G3) neuroendocrine carcinomas except primary lung cancerC75.9Endocrine gland, unspecified
- Registration Number
- DRKS00005433
- Lead Sponsor
- OSHO,Ostdeutsche Studiengruppe für Hämatologie und Onkologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with poorly differentiated (G3) neuroendocrine carcinoma except primary lung cancer
Exclusion Criteria
primary lung cancer G3
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival after first diagnosis
- Secondary Outcome Measures
Name Time Method Response to primary and salvage treatment regimens; progression-free survival, treatment-related adverse events